Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL30104219

COC(=O)[C@H](CC(C)C)NC(=O)c1ccc(NC[C@@H](N)CS)cc1-c1cccc2ccccc12.O=C(O)C(F)(F)F

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FNTA P49354 18/20 0.89
PGGT1B P53609 13/20 0.89
TDP1 Q9NUW8 3/20 0.89
FNTB P49356 16/20 0.78
TAS1R3 Q7RTX0 2/20 0.41
TAS1R1 Q7RTX1 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL16499777 1.00 FNTA (0.89) FNTAPGGT1BTDP1FNTBTAS1R3
Trifluoroacetic Acid SCHEMBL16499780 1.00 FNTA (0.89) FNTAPGGT1BTDP1FNTBTAS1R3
SCHEMBL16136630 0.94 FNTA (1.00) FNTAPGGT1BTDP1FNTBTAS1R3
SCHEMBL29392871 0.94 FNTA (1.00) FNTAPGGT1BTDP1FNTBTAS1R3
SCHEMBL4283635 0.94 FNTA (1.00) FNTAPGGT1BTDP1FNTBTAS1R3
Trifluoroacetic Acid SCHEMBL28675162 0.93 FNTA (0.91) FNTAPGGT1BTDP1FNTB
Trifluoroacetic Acid SCHEMBL31146895 0.93 FNTA (0.91) FNTAPGGT1BTDP1FNTB
Trifluoroacetic Acid SCHEMBL28675164 0.93 FNTA (0.91) FNTAPGGT1BTDP1FNTB
SCHEMBL25211622 0.91 FNTA (0.81) FNTAPGGT1BTDP1FNTB
SCHEMBL16136644 0.88 FNTA (1.00) FNTAPGGT1BTDP1FNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119385163-A Application of GGTI298 in prevention and control of rice blast 中国水稻研究所 2025-02-07 CN claimed
EP-4121430-A1 COMPOUNDS FOR TREATING OR INHIBITING RECURRENCE OF ACUTE MYELOID LEUKEMIA Flash Therapeuttics, LLC (US) 2023-01-25 EP claimed
EP-4619518-A1 METHOD OF MODIFYING CELLS Royal Melbourne Institute of Technology (AU) 2025-09-24 EP disclosed
US-20250281607-A1 MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER TORAY INDUSTRIES, INC. (JP) 2025-09-11 US disclosed
US-12298305-B2 Activated GTPase-based assays and kits for the diagnosis of sepsis and other infections UNM RAINFOREST INNOVATIONS (US) 2025-05-13 US disclosed
CN-119385163-A Application of GGTI298 in prevention and control of rice blast 中国水稻研究所 2025-02-07 CN disclosed
EP-4378478-A1 MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER Toray Industries, Inc. (JP) 2024-06-05 EP disclosed
WO-2024092321-A1 METHODS OF ENHANCING ENDOTHELIAL BARRIER INTEGRITY ROYAL MELBOURNE INSTITUTE OF TECHNOLOGY (AU) 2024-05-10 WO disclosed
US-20230226183-A1 COMPOSITIONS AND METHODS FOR ALTERING GAMMA DELTA T CELL ACTIVITY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-07-20 US disclosed
WO-2023008462-A1 MEDICAMENT FOR TREATMENT AND/OR PREVENTION OF CANCER 東レ株式会社 2023-02-02 WO disclosed